News

This article by Dr. Wiam I. Hussein discusses the growing interest in using insulin pumps for the intensive management of diabetes over the past 25 years. It highlights the significant findings from the Diabetes Control and Complications Trial (DCCT) in 1993, which demonstrated that intensive diabetes management through insulin pump therapy can substantially reduce the risks of eye, kidney, and nerve complications associated with diabetes, particularly in type 1 diabetes.

The article explains how insulin pumps work by providing continuous subcutaneous insulin infusion (CSII), closely mimicking the body's natural insulin secretion from the pancreas. This method of insulin delivery helps avoid the inconsistencies and gaps often associated with multiple daily injections, offering more precise control over blood glucose levels.

Insulin pump therapy is particularly effective in maintaining blood glucose levels within a narrow range, meeting the physiological needs of the body even during fasting, illness, stress, or pregnancy. However, the article also notes that while insulin pump therapy can benefit many, it may not be suitable for everyone, including those with specific types of diabetes like Gestational diabetes.